Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Diffuse Large B-Cell Lymphoma Unclassifiable
- Recurrent Diffuse Large B-Cell Lymphoma
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
- Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
Interventions
- DRUG: Carboplatin
- DRUG: Etoposide
- DRUG: Ifosfamide
- DRUG: Polatuzumab Vedotin
- BIOLOGICAL: Rituximab
Sponsor
City of Hope Medical Center
Collaborators